InvestorsHub Logo
Followers 14
Posts 2972
Boards Moderated 0
Alias Born 07/19/2006

Re: LutherTiggs post# 23105

Thursday, 06/11/2015 8:13:02 PM

Thursday, June 11, 2015 8:13:02 PM

Post# of 30990
A topical compound might be a quicker and less expensive route to approval. The burden of proof necessary to appease the FDA might not be as great, either.

Messages posted by individuals may be misleading, deceptive, or in error. If you disagree with a posting, feel free to voice your opinion. It is the policy of iHub to allow our members to freely discuss issues in a free and open manner

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.